New Mexico Educational Retirement Board’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.12M | Buy |
5,000
+200
| +4% | +$136K | 0.08% | 240 |
|
|
2026
Q1 | $3.71M | Hold |
4,800
| – | – | 0.11% | 153 |
|
|
2025
Q4 | $3.71M | Buy |
4,800
+100
| +2% | +$67.9K | 0.11% | 147 |
|
|
2025
Q3 | $2.64M | Sell |
4,700
-200
| -4% | -$113K | 0.08% | 226 |
|
|
2025
Q2 | $2.57M | Hold |
4,900
| – | – | 0.08% | 218 |
|
|
2025
Q1 | $3.11M | Sell |
4,900
-200
| -4% | -$138K | 0.11% | 156 |
|
|
2024
Q4 | $3.63M | Sell |
5,100
-100
| -2% | -$83.9K | 0.12% | 133 |
|
|
2024
Q3 | $5.47M | Sell |
5,200
-200
| -4% | -$223K | 0.18% | 85 |
|
|
2024
Q2 | $5.68M | Hold |
5,400
| – | – | 0.2% | 81 |
|
|
2024
Q1 | $5.2M | Sell |
5,400
-200
| -4% | -$190K | 0.19% | 91 |
|
|
2023
Q4 | $4.92M | Hold |
5,600
| – | – | 0.19% | 94 |
|
|
2023
Q3 | $4.61M | Buy |
5,600
+400
| +8% | +$314K | 0.2% | 88 |
|
|
2023
Q2 | $3.74M | Buy |
5,200
+200
| +4% | +$154K | 0.16% | 103 |
|
|
2023
Q1 | $4.11M | Sell |
5,000
-100
| -2% | -$75.4K | 0.21% | 89 |
|
|
2022
Q4 | $3.68M | Sell |
5,100
-400
| -7% | -$295K | 0.2% | 99 |
|
|
2022
Q3 | $3.79M | Sell |
5,500
-400
| -7% | -$252K | 0.21% | 88 |
|
|
2022
Q2 | $3.49M | Sell |
5,900
-300
| -5% | -$195K | 0.17% | 113 |
|
|
2022
Q1 | $4.33M | Sell |
6,200
-200
| -3% | -$127K | 0.16% | 108 |
|
|
2021
Q4 | $4.04M | Sell |
6,400
-500
| -7% | -$307K | 0.14% | 126 |
|
|
2021
Q3 | $4.18M | Sell |
6,900
-100
| -1% | -$62.1K | 0.15% | 123 |
|
|
2021
Q2 | $3.91M | Buy |
7,000
+600
| +9% | +$304K | 0.13% | 131 |
|
|
2021
Q1 | $3.03M | Hold |
6,400
| – | – | 0.12% | 147 |
|
|
2020
Q4 | $3.09M | Sell |
6,400
-100
| -2% | -$54K | 0.13% | 136 |
|
|
2020
Q3 | $3.64M | Sell |
6,500
-300
| -4% | -$182K | 0.17% | 108 |
|
|
2020
Q2 | $4.24M | Buy |
6,800
+1,800
| +36% | +$1.02M | 0.2% | 90 |
|
|
2020
Q1 | $2.44M | Sell |
5,000
-1,100
| -18% | -$454K | 0.15% | 133 |
|
|
2019
Q4 | $2.29M | Hold |
6,100
| – | – | 0.1% | 197 |
|
|
2019
Q3 | $1.69M | Sell |
6,100
-300
| -5% | -$88.8K | 0.08% | 262 |
|
|
2019
Q2 | $2M | Sell |
6,400
-100
| -2% | -$33.3K | 0.09% | 228 |
|
|
2019
Q1 | $2.67M | Sell |
6,500
-100
| -2% | -$41.2K | 0.11% | 175 |
|
|
2018
Q4 | $2.46M | Sell |
6,600
-300
| -4% | -$110K | 0.12% | 170 |
|
|
2018
Q3 | $2.79M | Sell |
6,900
-200
| -3% | -$76.1K | 0.11% | 185 |
|
|
2018
Q2 | $2.45M | Sell |
7,100
-200
| -3% | -$62.5K | 0.1% | 206 |
|
|
2018
Q1 | $2.51M | Sell |
7,300
-100
| -1% | -$34.8K | 0.1% | 219 |
|
|
2017
Q4 | $2.78M | Buy |
7,400
+300
| +4% | +$122K | 0.11% | 190 |
|
|
2017
Q3 | $3.17M | Hold |
7,100
| – | – | 0.15% | 164 |
|
|
2017
Q2 | $3.49M | Sell |
7,100
-600
| -8% | -$263K | 0.17% | 142 |
|
|
2017
Q1 | $2.98M | Sell |
7,700
-400
| -5% | -$148K | 0.14% | 182 |
|
|
2016
Q4 | $2.97M | Buy |
8,100
+200
| +3% | +$76.1K | 0.14% | 182 |
|
|
2016
Q3 | $3.18M | Sell |
7,900
-1,200
| -13% | -$481K | 0.16% | 158 |
|
|
2016
Q2 | $3.18M | Buy |
9,100
+500
| +6% | +$193K | 0.14% | 169 |
|
|
2016
Q1 | $3.1M | Buy |
8,600
+200
| +2% | +$82.4K | 0.15% | 164 |
|
|
2015
Q4 | $4.56M | Sell |
8,400
-200
| -2% | -$108K | 0.22% | 113 |
|
|
2015
Q3 | $4M | Buy |
8,600
+800
| +10% | +$430K | 0.2% | 129 |
|
|
2015
Q2 | $3.98M | Sell |
7,800
-800
| -9% | -$390K | 0.19% | 136 |
|
|
2015
Q1 | $3.88M | Sell |
8,600
-300
| -3% | -$127K | 0.17% | 152 |
|
|
2014
Q4 | $3.65M | Sell |
8,900
-1,000
| -10% | -$393K | 0.15% | 166 |
|
|
2014
Q3 | $3.57M | Sell |
9,900
-400
| -4% | -$134K | 0.14% | 171 |
|
|
2014
Q2 | $2.91M | Hold |
10,300
| – | – | 0.12% | 210 |
|
|
2014
Q1 | $3.09M | Buy |
+10,300
| New | +$3.17M | 0.13% | 191 |
|
|
2013
Q3 | – | Sell |
-12,100
| Closed | -$2.72M | – | 904 |
|
|
2013
Q2 | $2.72M | Buy |
+12,100
| New | +$2.82M | 0.11% | 211 |
|
Other funds holding REGN
MCI
New Mexico Educational Retirement Board's REGN Position: Q2 2026 in Review
New Mexico Educational Retirement Board increased its Regeneron Pharmaceuticals (REGN) stake by 4.2% in Q2 2026, buying an estimated $136K and bringing the position to 5,000 shares worth $3.12M. The position accounts for 0.08% of the portfolio, ranked #240.
New Mexico Educational Retirement Board first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.68M in Q2 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- New Mexico Educational Retirement Board held 5,000 shares of Regeneron Pharmaceuticals worth $3.12M as of Q2 2026.
- New Mexico Educational Retirement Board bought 200 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $136K.
- Regeneron Pharmaceuticals made up 0.08% of New Mexico Educational Retirement Board's portfolio in Q2 2026, its #240 holding.
- New Mexico Educational Retirement Board first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- New Mexico Educational Retirement Board's Regeneron Pharmaceuticals position peaked at $5.68M in Q2 2024.
- 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on New Mexico Educational Retirement Board's 13F filing for Q2 2026, filed 29 Jul 2026.